Curly T C M Morris (Gordon Cook)

ORCID

Publication Activity (10 Years)

Years Active: 2018-2023
Publications (10 Years): 41

Top Venues

British journal of haematology

Leukemia

Blood cancer journal

Journal of clinical oncology : official journal of the American Society of Clinical Oncology

University of Glasgow (PHD)

This page only lists publications with an associated author ORCID identifier.

Education History

University of Glasgow

United Kingdom

PHD :: Medicine

Publications

Rebecca J Brownlie, Ruth Kennedy, Erica B Wilson, Maja Milanovic, Claire F Taylor, Dapeng Wang, John Davies, Heather Elizabeth Owston, Emma J Adams, Sophie Stephenson, Rebecca Caeser, Benjamin E Gewurz, Peter V Giannoudis, Claudio Scuoppo, Dennis McGonagle, Daniel James Hodson, Reuben M Tooze, Gina M Doody, Curly T C M Morris, David Robert Westhead, Ulf Klein
Cytokine receptor IL27RA is an NF-kB-responsive gene involved in CD38 upregulation in multiple myeloma. Blood advances (2023)
Martin F Kaiser, Andrew Hall, Katrina Walker, Amy Sherborne, Ruth M De Tute, Nicola Newnham, Sadie Roberts, Emma Ingleson, Kristian M Bowles, Mamta Garg, Anand Lokare, Christina Messiou, Richard S Houlston, Graham H Jackson, Curly T C M Morris, Guy Pratt, Roger G Owen, Mark T Drayson, Sarah R Brown, Matthew W Jenner
Daratumumab, Cyclophosphamide, Bortezomib, Lenalidomide, and Dexamethasone as Induction and Extended Consolidation Improves Outcome in Ultra-High-Risk Multiple Myeloma. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2023)
Hira S Mian, Arleigh McCurdy, Smith Giri, Shakira J Grant, Bram Rochwerg, Erica Winks, Ashley E Rosko, Monika Engelhardt, Charlotte Pawlyn, Curly T C M Morris, Graham Jackson, Sara Bringhen, Thierry Facon, Alessandra Larocca, Sonja Zweegman, Tanya M Wildes
The prevalence and outcomes of frail older adults in clinical trials in multiple myeloma: A systematic review. Blood cancer journal 13 (1) (2023)
Hira S Mian, Arleigh McCurdy, Smith Giri, Shakira J Grant, Bram Rochwerg, Erica Winks, Ashley E Rosko, Monika Engelhardt, Charlotte Pawlyn, Curly T C M Morris, Graham Jackson, Sara Bringhen, Thierry Facon, Alessandra Larocca, Sonja Zweegman, Tanya M Wildes
The prevalence and outcomes of frail older adults in clinical trials in multiple myeloma: A systematic review. Blood cancer journal 13 (1) (2023)
Sian E Faustini, Andrew Hall, Sarah R Brown, Sadie Roberts, Harriet Hill, Zania Stamataki, null null, Matthew W Jenner, Roger G Owen, Guy Pratt, Curly T C M Morris, Alex Richter, Mark T Drayson, Martin F Kaiser, Jennifer L J Heaney
Immune responses to COVID-19 booster vaccinations in intensively anti-CD38 antibody treated patients with ultra-high-risk multiple myeloma: results from the Myeloma UK (MUK) nine OPTIMUM trial. British journal of haematology (2023)
Hira S Mian, Arleigh McCurdy, Smith Giri, Shakira J Grant, Bram Rochwerg, Erica Winks, Ashley E Rosko, Monika Engelhardt, Charlotte Pawlyn, Curly T C M Morris, Graham Jackson, Sara Bringhen, Thierry Facon, Alessandra Larocca, Sonja Zweegman, Tanya M Wildes
The prevalence and outcomes of frail older adults in clinical trials in multiple myeloma: A systematic review. Blood cancer journal 13 (1) (2023)
Evangelos Terpos, Pellegrino Musto, Monika Engelhardt, Michel Delforge, Curly T C M Morris, Francesca Gay, Niels W C J van de Donk, Ioannis Ntanasis-Stathopoulos, Annette Juul Vangsted, Christoph Driessen, Schjesvold Fredrik, Claudio Cerchione, Sonja Zweegman, Roman Hájek, Phillipe Moreau, Hermann Einsele, Jesús San F Miguel, Mario Boccadoro, Meletios- Athanasios Dimopoulos, Pieter Sonneveld, Heinz Ludwig
Management of patients with multiple myeloma and COVID-19 in the post pandemic era: a consensus paper from the European Myeloma Network (EMN). Leukemia (2023)
Lesley Smith, Jonathan Carmichael, Curly T C M Morris, Bethany Shinkins, Richard D Neal
Development and Internal Validation of a Risk Prediction Model to Identify Myeloma Based on Routine Blood Tests: A Case-Control Study. Cancers 15 (3) (2023)
Hira S Mian, Arleigh McCurdy, Smith Giri, Shakira J Grant, Bram Rochwerg, Erica Winks, Ashley E Rosko, Monika Engelhardt, Charlotte Pawlyn, Curly T C M Morris, Graham Jackson, Sara Bringhen, Thierry Facon, Alessandra Larocca, Sonja Zweegman, Tanya M Wildes
The prevalence and outcomes of frail older adults in clinical trials in multiple myeloma: A systematic review. Blood cancer journal 13 (1) (2023)
Evangelos Terpos, Pellegrino Musto, Monika Engelhardt, Michel Delforge, Curly T C M Morris, Francesca Gay, Niels W C J van de Donk, Ioannis Ntanasis-Stathopoulos, Annette Juul Vangsted, Christoph Driessen, Schjesvold Fredrik, Claudio Cerchione, Sonja Zweegman, Roman Hájek, Phillipe Moreau, Hermann Einsele, Jesús San F Miguel, Mario Boccadoro, Meletios- Athanasios Dimopoulos, Pieter Sonneveld, Heinz Ludwig
Management of patients with multiple myeloma and COVID-19 in the post pandemic era: a consensus paper from the European Myeloma Network (EMN). Leukemia (2023)
Hira S Mian, Arleigh McCurdy, Smith Giri, Shakira J Grant, Bram Rochwerg, Erica Winks, Ashley E Rosko, Monika Engelhardt, Charlotte Pawlyn, Curly T C M Morris, Graham Jackson, Sara Bringhen, Thierry Facon, Alessandra Larocca, Sonja Zweegman, Tanya M Wildes
The prevalence and outcomes of frail older adults in clinical trials in multiple myeloma: A systematic review. Blood cancer journal 13 (1) (2023)
Lesley Smith, Jonathan Carmichael, Curly T C M Morris, Bethany Shinkins, Richard D Neal
Development and Internal Validation of a Risk Prediction Model to Identify Myeloma Based on Routine Blood Tests: A Case-Control Study. Cancers 15 (3) (2023)
Aikaterini Panopoulou, David A Cairns, Amy Elizabeth Holroyd, Isabel Nichols, Nikita Cray, Charlotte Pawlyn, Curly T C M Morris, Mark T Drayson, Kevin D Boyd, Faith E Davies, Matthew W Jenner, Gareth J Morgan, Roger G Owen, Richard S Houlston, Graham H Jackson, Martin F Kaiser
Optimizing the value of lenalidomide maintenance by genetic profiling - an analysis of 556 Myeloma XI trial patients. Blood (2022)
Ruth M de Tute, Charlotte Pawlyn, David A Cairns, Faith E Davies, Tom Menzies, Andrew C Rawstron, John R Jones, Anna Hockaday, Rowena Henderson, Curly T C M Morris, Mark T Drayson, Matthew W Jenner, Martin F Kaiser, Walter M Gregory, Gareth J Morgan, Graham H Jackson, Roger G Owen
Minimal Residual Disease After Autologous Stem-Cell Transplant for Patients With Myeloma: Prognostic Significance and the Impact of Lenalidomide Maintenance and Molecular Risk. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 40 (25) (2022)
John A Snowden, Sam H Ahmedzai, Angela Cox, David A Cairns, A John Ashcroft, Cathy Williams, Jamie D Cavenagh, Anna Hockaday, Julia M Brown, Ian W Brock, Treen C M Morris, Curly T C M Morris, null null
Association of genetic variants with patient reported quality of life and pain experience in patients in the UK NCRI Myeloma X Relapse [Intensive]) trial; an exploratory study. Bone marrow transplantation 57 (10) (2022)
Aikaterini Panopoulou, David A Cairns, Amy Elizabeth Holroyd, Isabel Nichols, Nikita Cray, Charlotte Pawlyn, Curly T C M Morris, Mark T Drayson, Kevin D Boyd, Faith E Davies, Matthew W Jenner, Gareth J Morgan, Roger G Owen, Richard S Houlston, Graham H Jackson, Martin F Kaiser
Optimizing the value of lenalidomide maintenance by genetic profiling - an analysis of 556 Myeloma XI trial patients. Blood (2022)
Karthik Ramasamy, Ross Sadler, Sally Jeans, Paul Weeden, Sherin Varghese, Alison Turner, Jemma Larham, Nathanael Gray, Oluremi Carty, Joe Barrett, Stella Bowcock, Udo Oppermann, Curly T C M Morris, Chara Kyriakou, Mark Drayson, Supratik Basu, Sally Moore, Sarah McDonald, Sarah Gooding, Muhammad K Javaid
Immune response to COVID-19 vaccination is attenuated by poor disease control and antimyeloma therapy with vaccine driven divergent T-cell response. British journal of haematology 197 (3) (2022)
Frances Seymour, Jonathan Carmichael, Claire Taylor, Christopher Parrish, Curly T C M Morris
Immune senescence in multiple myeloma-a role for mitochondrial dysfunction? Leukemia 36 (10) (2022)
Matthew W Jenner, Charlotte Pawlyn, Faith E Davies, Tom Menzies, Anna Hockaday, Catherine Olivier, John R Jones, Kamuraj Karunanithi, Jindriska Lindsay, Bhuvan Kishore, Curly T C M Morris, Mark T Drayson, Martin F Kaiser, Roger G Owen, Walter Gregory, David A Cairns, Gareth J Morgan, Graham H Jackson, null null
The addition of vorinostat to lenalidomide maintenance for patients with newly diagnosed multiple myeloma of all ages: results from 'Myeloma XI', a multicentre, open-label, randomised, phase III trial. British journal of haematology (2022)
Matthew W Jenner, Charlotte Pawlyn, Faith E Davies, Tom Menzies, Anna Hockaday, Catherine Olivier, John R Jones, Kamaraj Karunanithi, Jindriska Lindsay, Bhuvan Kishore, Curly T C M Morris, Mark T Drayson, Martin F Kaiser, Roger G Owen, Walter Gregory, David A Cairns, Gareth J Morgan, Graham H Jackson, null null
The addition of vorinostat to lenalidomide maintenance for patients with newly diagnosed multiple myeloma of all ages: results from 'Myeloma XI', a multicentre, open-label, randomised, phase III trial. British journal of haematology (2022)
Holger W Auner, Sarah R Brown, Katrina Walker, Jessica Kendall, Bryony Dawkins, David Meads, Gareth J Morgan, Martin F Kaiser, Mark Cook, Sadie Roberts, Christopher Parrish, Curly T C M Morris
Ixazomib with cyclophosphamide and dexamethasone in relapsed or refractory myeloma: MUKeight phase II randomised controlled trial results. Blood cancer journal 12 (4) (2022)
Matthew W Jenner, Charlotte Pawlyn, Faith E Davies, Tom Menzies, Anna Hockaday, Catherine Olivier, John R Jones, Kamuraj Karunanithi, Jindriska Lindsay, Bhuvan Kishore, Curly T C M Morris, Mark T Drayson, Martin F Kaiser, Roger G Owen, Walter Gregory, David A Cairns, Gareth J Morgan, Graham H Jackson, null null
The addition of vorinostat to lenalidomide maintenance for patients with newly diagnosed multiple myeloma of all ages: results from 'Myeloma XI', a multicentre, open-label, randomised, phase III trial. British journal of haematology (2022)
Mattia D'Agostino, David A Cairns, Juan-José Lahuerta, Ruth Wester, Uta Bertsch, Anders Waage, Elena Zamagni, Maria-Victoria Mateos-Manteca, Daniele Dall'Olio, Niels W C J van de Donk, Graham H Jackson, Serena Rocchi, Hans J Salwender, Joan Bladé Creixenti, Bronno van der Holt, Gastone C Castellani, Francesca Bonello, Andrea Capra, Elias Karl Mai, Jan Dürig, Francesca Gay, Sonja Zweegman, Michele Cavo, Martin F Kaiser, Hartmut Goldschmidt, Jesús María Hernández-Rivas, Alessandra Larocca, Curly T C M Morris, Jesús San F Miguel, Mario Boccadoro, Pieter Sonneveld
Second Revision of the International Staging System (R2-ISS) for Overall Survival in Multiple Myeloma: A European Myeloma Network (EMN) Report Within the HARMONY Project. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 40 (29) (2022)
Wei Yee Chan, Nicholas Counsell, Ruth de Tute, Dunnya De-Silva, Elizabeth H Phillips, Jamie Cavenagh, Toyin Adedayo, Nivette Braganca, Claire Roddie, Matthew Streetly, Stephen Schey, Mickey B C Koh, Josephine Crowe, Treen C Morris, Curly T C M Morris, Laura Clifton-Hadley, Neil Rabin, Roger G Owen, Rakesh Popat, Kwee L Yong, null null
Outcomes of relapse in patients with deferred autologous stem cell transplant after achieving at least very good partial response following bortezomib, adriamycin, dexamethasone chemotherapy for newly diagnosed multiple myeloma in the phase II PADIMAC trial. British journal of haematology (2021)
Curly T C M Morris, Alessandro Corso, Matthew Streetly, Larisa P Mendeleeva, Vadim V Ptushkin, Edmond Chan, Jon Ukropec, Wafae Iraqi, Assem Al-Akabawi, Huiling Pei, Maren Gaudig, Maria Teresa Petrucci, Adrian Alegre, Maria-Victoria Mateos
Daratumumab Monotherapy for Relapsed or Refractory Multiple Myeloma: Results of an Early Access Treatment Protocol in Europe and Russia. Oncology and therapy 9 (1) (2021)
Marquita Camilleri, Maria Cuadrado, Elizabeth Phillips, William Wilson, Richard Jenner, Gavin Pang, Sumaiya Kamora, Matthew Streetly, Rakesh Popat, Ceri A Bygrave, Roger Owen, James Cavenagh, Mike Chapman, Jonathan Sive, Lydia Eccersley, Michael Sheaff, Reuben Benjamin, Karthik Ramasamy, Curly T C M Morris, Andres Virchis, Selina J Chavda, Laura Clifton-Hadley, Marie Anne Scully, Kwee L Yong
Thrombotic microangiopathy in untreated myeloma patients receiving carfilzomib, cyclophosphamide and dexamethasone on the CARDAMON study. British journal of haematology 193 (4) (2021)
Torben Plesner, Meletios- Athanasios Dimopoulos, Albert Oriol, Jesús San F Miguel, Nizar J Bahlis, Neil Rabin, Kenshi Suzuki, Sung-Soo Yoon, Dina Ben-Yehuda, Curly T C M Morris, Hartmut Goldschmidt, Sebastian Grosicki, Xiang Qin, John Fastenau, Wendy Garvin, Robin Carson, Thomas Renaud, Katharine S Gries
Health-related quality of life in patients with relapsed or refractory multiple myeloma: treatment with daratumumab, lenalidomide, and dexamethasone in the phase 3 POLLUX trial. British journal of haematology 194 (1) (2021)
Stephen Booth, Helen M Curley, Csilla Varnai, Roland Arnold, Lennard Y W Lee, Naomi A Campton, Curly T C M Morris, Karin Purshouse, James Aries, Andrew Innes, Lucy B Cook, Oliver Tomkins, Helen S Oram, Michael Tilby, Austin G Kulasekararaj, David Wrench, Saoirse Dolly, Tom Newsom-Davies, Ruth Pettengell, Abigail Gault, Sam Moody, Sajjan Mittal, Mohammed O A Altohami, Tania Tillet, Jack Illingworth, Leena Mukherjee, Jane Apperly, John Ashcroft, Neil Rabin, Jonathan Carmichael, Jean-Baptiste Cazier, Rachel Kerr, Gary Middleton, Graham P Collins, Claire Palles, null null
Key findings from the UKCCMP cohort of 877 patients with haematological malignancy and COVID-19: disease control as an important factor relative to recent chemotherapy or anti-CD20 therapy. British journal of haematology (2021)
Treen C Morris, Curly T C M Morris
Evolution or revolution in multiple myeloma therapy and the role of the UK. British journal of haematology 191 (4) (2021)
Karthik Ramasamy, Ross Sadler, Sally Jeans, Sherin Varghese, Alison Turner, Jemma Larham, Nathanael Gray, Joe Barrett, Stella Bowcock, Curly T C M Morris, Chara Kyriakou, Dean Smith, Mark Drayson, Supratik Basu, Sally Moore, Sarah McDonald, Sarah Gooding, Muhammad K Javaid
COVID symptoms, testing, shielding impact on patient-reported outcomes and early vaccine responses in individuals with multiple myeloma. British journal of haematology (2021)
Rakesh Popat, Nicholas Counsell, Ruth de Tute, Dunnya De-Silva, Elizabeth H Phillips, Jamie D Cavenagh, Toyin Adedayo, Nivette Braganca, Claire Roddie, Matthew Streetly, Steve Schey, Mickey B C Koh, Josephine Crowe, Treen C Morris, Curly T C M Morris, Paul Smith, Laura Clifton-Hadley, Neil Rabin, Roger Owen, Kwee L Yong, null null
Using depth of response to stratify patients to front line Autologous Stem Cell Transplant: results of the phase II PADIMAC Myeloma Trial. British journal of haematology 193 (3) (2021)
Phuc H Hoang, Alex J Cornish, Amy L Sherborne, Daniel Chubb, Scott Kimber, Graham Jackson, Gareth J Morgan, Curly T C M Morris, Ben Kinnersley, Martin F Kaiser, Richard S Houlston
An enhanced genetic model of relapsed IGH-translocated multiple myeloma evolutionary dynamics. Blood cancer journal 10 (10) (2020)
Luciano José Megale Costa, Benjamin A Derman, Susan Bal, Surbhi Sidana, Saurabh Chhabra, Rebecca Silbermann, Jing C Ye, Curly T C M Morris, Robert F Cornell, Sarah A Holstein, Qian Shi, James Omel, Natalie S Callander, Wee Joo Chng, Vania Hungria, Ângelo Maiolino, Edward Stadtmauer, Sergio A Giralt, Marcelo Pasquini, Andrzej J Jakubowiak, Gareth J Morgan, Amrita Krishnan, Graham H Jackson, Mohamad Mohty, Maria-Victoria Mateos-Manteca, Meletious A Dimopoulos, Thierry Facon, Andrew Spencer, Jesus San Miguel, Parameswaran Hari, Saad Z Usmani, Salomon Manier, Phillip McCarthy, Shaji K Kumar, Francesca Gay, Juan José Lahuerta
International harmonization in performing and reporting minimal residual disease assessment in multiple myeloma trials. Leukemia 35 (1) (2020)
James Croft, Sidra Ellis, Amy L Sherborne, Kim Sharp, Amy Price, Matthew W Jenner, Mark T Drayson, Roger G Owen, Sally Chown, Jindriska Lindsay, Kamaraj Karunanithi, Hannah Hunter, Walter Martin Gregory, Faith E Davies, Gareth J Morgan, Curly T C M Morris, Lilit Atanesyan, Suvi Savola, David A Cairns, Graham Jackson, Richard S Houlston, Martin F Kaiser
Copy number evolution and its relationship with patient outcome-an analysis of 178 matched presentation-relapse tumor pairs from the Myeloma XI trial. Leukemia 35 (7) (2020)
Vallari Shah, Amy L Sherborne, David C Johnson, Sidra Ellis, Amy Price, Farzana Chowdhury, Jack Kendall, Matthew W Jenner, Mark T Drayson, Roger G Owen, Walter M Gregory, Gareth J Morgan, Faith E Davies, Curly T C M Morris, David A Cairns, Richard S Houlston, Graham Jackson, Martin F Kaiser, null null
Predicting ultrahigh risk multiple myeloma by molecular profiling: an analysis of newly diagnosed transplant eligible myeloma XI trial patients. Leukemia 34 (11) (2020)
Curly T C M Morris, A John Ashcroft, Guy Pratt, Rakesh Popat, Karthik Ramasamy, Martin F Kaiser, Matthew Jenner, Sarah Henshaw, Rachel Hall, Jonathan Sive, Simon Stern, Matthew Streetly, Ceri A Bygrave, Richard Soutar, Neil Rabin, Graham H Jackson, null null
Real-world assessment of the clinical impact of symptomatic infection with severe acute respiratory syndrome coronavirus (COVID-19 disease) in patients with multiple myeloma receiving systemic anti-cancer therapy. British journal of haematology 190 (2) (2020)
Curly T C M Morris, Alessandra Larocca, Thierry Facon, Sonja Zweegman, Monika Engelhardt
Defining the vulnerable patient with myeloma-a frailty position paper of the European Myeloma Network. Leukemia 34 (9) (2020)
Graham H Jackson, Charlotte Pawlyn, David A Cairns, Alina Striha, Corinne Collett, Anna Waterhouse, John R Jones, Jamie Wilson, Craig Taylor, Bhuvan Kishore, Mamta Garg, Cathy D Williams, Kamaraj Karunanithi, Jindriska Lindsay, Matthew W Jenner, Curly T C M Morris, Nigel H Russell, Mark T Drayson, Martin F Kaiser, Roger G Owen, Walter M Gregory, Faith E Davies, Gareth J Morgan, null null
Optimising the value of immunomodulatory drugs during induction and maintenance in transplant ineligible patients with newly diagnosed multiple myeloma: results from Myeloma XI, a multicentre, open-label, randomised, Phase III trial. British journal of haematology 192 (5) (2020)
Nizar J Bahlis, Meletios A Dimopoulos, Darrell J White, Lotfi Benboubker, Curly T C M Morris, Merav Leiba, P Joy Ho, Kihyun Kim, Naoki Takezako, Philippe Moreau, Jonathan L Kaufman, Maria Krevvata, Christopher Chiu, Xiang Qin, Linda Okonkwo, Sonali Trivedi, Jon Ukropec, Ming Qi, Jesus San-Miguel
Daratumumab plus lenalidomide and dexamethasone in relapsed/refractory multiple myeloma: extended follow-up of POLLUX, a randomized, open-label, phase 3 study. Leukemia 34 (7) (2020)
Katja C Weisel, Maria-Victoria Mateos-Manteca, Francesca Gay, Michel Delforge, Curly T C M Morris, Zsolt Szabo, Renaud Desgraz, Lucy DeCosta, Philippe Moreau
Efficacy and safety profile of deep responders to carfilzomib-based therapy: a subgroup analysis from ASPIRE and ENDEAVOR. Leukemia 35 (6) (2020)
Alina Striha, A John Ashcroft, Anna Hockaday, David A Cairns, Karen Boardman, Gwen Jacques, Cathy Williams, John A Snowden, Mamta Garg, Jamie Cavenagh, Kwee Yong, Mark T Drayson, Roger Owen, Mark Cook, Curly T C M Morris
The role of ixazomib as an augmented conditioning therapy in salvage autologous stem cell transplant (ASCT) and as a post-ASCT consolidation and maintenance strategy in patients with relapsed multiple myeloma (ACCoRd [UK-MRA Myeloma XII] trial): study protocol for a Phase III randomised controlled trial. Trials 19 (1) (2018)

Curly T C M Morris.css-eqlu8i{font-size:small;padding-left:4px;} (Gordon Cook)

Publication Activity (10 Years)

Top Topics

Top Venues

Curly T C M Morris (Gordon Cook)